About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Leukemia Clinical Trials in Houston | 46 Studies

Clinical Trials LeukemiaHouston

Leukemia Clinical Trials in Houston

Find 46 clinical trials for leukemia near Houston, Texas. Connect with research centers in your area.

All Leukemia trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 46 trials

CompletedEngineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesThis pilot phase I trial studies the side effects of engineered donor stem cell transplant in treating patients with hematologic malignancies.NCT02960646·Houston, Texas CompletedUmbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or LymphomaThis phase II trial studies how well an umbilical cord blood transplant with added sugar works with chemotherapy and radiation therapy in treating patients with leukemia or…NCT03096782·Houston, Texas

Leukemia Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedFTS Study in Patients With Advanced Hematologic MalignanciesPrimary Objective: Determining the maximum tolerated dose (MTD) and pharmacokinetics (PK) of FTS (S-Trans, Trans-Farnesylthiosalicylic Acid) after daily oral administration on…NCT00867230·Houston, Texas

Completed4'-Thio-araC (Thiarabine) in Advanced Hematologic MalignanciesThe goal of this clinical research study is to find the highest tolerable dose of 4'-thio-araC (thiarabine) that can be given to patients with advanced blood cancer.NCT01139151·Houston, Texas

TerminatedBlood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure StatesThe purpose of this study is to assess early treatment failure within 100 days and to assess the effect of this regimen on engraftment, GVHD, immune recovery, relapse of…NCT00038779·Houston, Texas

CompletedNovel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)Acute Graft-versus-Host-Disease (GVHD) is an important cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT).NCT02208037·Duarte, California and 29 others

CompletedMK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaThis phase I trial is studying the side effects, best way to give, and best dose of Akt inhibitor MK2206 (MK2206) in treating patients with recurrent or refractory solid tumors or…NCT01231919·Birmingham, Alabama and 24 others

CompletedChemotherapy in Treating Patients Who Have Hematologic CancerRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00004047·Houston, Texas

TerminatedA Phase I Study of CYC140, a PLK-1 Inhibitor, in Advanced Leukemias or MDSA Phase I Pharmacologic Study of CYC140, a polo-like kinase 1 inhibitor, in Patients with Advanced Leukemias or Myelodysplastic SyndromesNCT03884829·Houston, Texas

CompletedStudy of Hypoxia-Activated Prodrug TH-302 to Treat Advanced LeukemiasThe primary objective of this study is to determine the maximum tolerated dose, dose limiting toxicity, safety and tolerability of TH-302 in patients with acute leukemias…NCT01149915·Houston, Texas

TerminatedSunitinib in Treating Patients With Idiopathic MyelofibrosisThis phase II trial is studying how well sunitinib works in treating patients with idiopathic myelofibrosis.NCT00387426·Houston, Texas

RecruitingCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionThis study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection.NCT05334069·Anchorage, Alaska and 746 others

Active not recruitingCytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell TransplantThis phase I/II trial studies how well cytokine-treated veto cells work in treating patients with hematologic malignancies following stem cell transplant.NCT03622788·Houston, Texas

TerminatedTXA127 in Enhancement of Engraftment in Adult Double Cord Blood TransplantationThe purpose of this study is to evaluate the effect of TXA127 on neutrophil and platelet counts in adult patients who have undergone a double cord blood transplant.NCT01300611·Houston, Texas

CompletedINCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative DiseaseRATIONALE: INCB18424 (Ruxolitinib) may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.NCT01164163·Birmingham, Alabama and 23 others

TerminatedMethadone, Morphine, or Oxycodone in Treating Pain in Patients With CancerRATIONALE: Methadone, morphine, or oxycodone may help relieve pain caused by cancer.NCT00726830·Spartanburg, South Carolina and 1 other

CompletedRAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell LymphomaThe goal of this clinical research study is to find the highest safe dose of RAD001 that can be given as a treatment for leukemia, mantle cell lymphoma, or myelofibrosis.NCT00081874·Houston, Texas

Completed3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic SyndromeRATIONALE: Drugs used in chemotherapy, such as fludarabine, work in different ways to stop cancer cells from dividing so they stop growing or die.NCT00077558·Atlanta, Georgia and 3 others

CompletedFenretinide in Treating Patients With Refractory or Relapsed Hematologic CancerRATIONALE: Drugs used in chemotherapy, such as fenretinide, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from…NCT00104923·Los Angeles, California and 3 others

CompletedA Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic MalignanciesPatients with refractory or relapsed hematologic malignancies will receive CP-4055 intravenously(IV) on Day 1-5 every three weeks until complete response or disease…NCT00405743·Valhalla, New York and 15 others

PreviousPage 2 of 3Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Lymphoma